Affiliation:
1. Department of Medical Specialties II, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
2. Department of Oncology, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
Abstract
Age is but one significant prognostic factor in lung cancer, influencing survival, treatment response, and outcomes. This narrative review synthesizes findings from searches of 11 leading databases of research studies, systematic reviews, book chapters, and clinical trial reports on lung cancer in senior patients, with a focus on geriatric assessment as well as biomarkers. Key prognostic factors for lung cancer in seniors include biological age, functional capability, physical and psychological comorbidities, frailty, nutrition, status, and biomarkers like DNA methylation age. We identified the most valuable assessments that balance efficacy with quality of life. Optimizing care and improving outcomes with senior lung cancer patients benefits from a tailored therapeutic approach incorporating a complex geriatric assessment. A multidisciplinary collaboration between geriatricians, oncologists, and pulmonologists is crucial.
Reference111 articles.
1. Abraham, J., Gulley, J.L., and Allegra, C.J. (2000). Bethesda Handbook of Clinical Oncology, Lippincott Williams & Wilkins.
2. The Oldest Old: A National Analysis of Outcomes for Patients 90 Years or Older with Lung Cancer;Yang;Ann. Thorac. Surg.,2020
3. Lung cancer in the elderly patient;Matthay;Clin. Chest Med.,1993
4. The management of elderly patients with lung cancer: A single center retrospective study;Wang;Ann. Palliat. Med.,2021
5. Niederhuber, J.E., Armitage, J.O., Doroshow, J.H., Kastan, M.B., and Tepper, J.E. (2013). Abeloff’s Clinical Oncology e-Book, Elsevier Health Sciences.